
This article by Elisabetta Fato was originally published on Microdose and appears here with permission.
Preliminary results from Phase 1 DMT clinical trial for depression support the safety and tolerability of the compound. With a world-first Phase 2 trial getting underway, we are on the cusp of potential breakthroughs in mental health treatments.